Targeting cellular cholesterol for anticancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting cellular cholesterol for anticancer therapy

Published:2019-08-12 Issue:21 Volume:286 Page:4192-4208
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Gu Liang¹,Saha Sourav Taru¹,Thomas Jodie¹,Kaur Mandeep¹^ORCID

Affiliation:

1. School of Molecular and Cell Biology University of the Witwatersrand Johannesburg South Africa

Funder

National Research Foundation

University of the Witwatersrand, Johannesburg

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15018

Reference152 articles.

1. GLOBOCAN(2016)Breast Cancer.http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp

2. Molecular chess? Hallmarks of anti-cancer drug resistance

3. Cancer drug resistance: an evolving paradigm

4. The Different Mechanisms of Cancer Drug Resistance: A Brief Review

5. Cholesterol metabolism and cancer: the good, the bad and the ugly

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we reduce cancer progression via disrupting autophagy-cholesterol uptake nexus?;Medical Hypotheses;2024-11

2. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers;Journal of Experimental & Clinical Cancer Research;2024-09-06

3. Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study;Frontiers in Endocrinology;2024-08-13

4. Cholesteryl ester transfer protein knock‐down in conjunction with a cholesterol‐depleting agent decreases tamoxifen resistance in breast cancer cells;IUBMB Life;2024-05-11

5. Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds;Nature Communications;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3